Publication | Open Access
Adalimumab biosimilars in the therapy of Crohn´s disease and ulcerative colitis: Prospective multicentric clinical monitoring
10
Citations
30
References
2022
Year
This prospective observational study proved the effectiveness of the adalimumab biosimilars FKB327 and GP2017 in IBD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1